Prothena
PRTA
₹595.28
Share price
2.84%
Change (1 day)
-70.35%
Change (1 year)
Categories
Prothena (PRTA) - Total liabilities
Total liabilities on the balance sheet as of March 2025 : ₹4.99 Billion
According to Prothena's latest financial reports the company's total liabilities are ₹4.99 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Prothena - Total liabilities on balance sheet (from 2012 to 2025)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2024-12-31 | ₹5.16 B | -54.07% |
| 2023-12-31 | ₹11.24 B | -0.12% |
| 2022-12-31 | ₹11.25 B | 5.49% |
| 2021-12-31 | ₹10.66 B | -2.08% |
| 2020-12-31 | ₹10.89 B | 4.39% |
| 2019-12-31 | ₹10.43 B | -15.1% |
| 2018-12-31 | ₹12.29 B | 115.97% |
| 2017-12-31 | ₹5.69 B | -11.44% |
| 2016-12-31 | ₹6.42 B | 293.65% |
| 2015-12-31 | ₹1.63 B | 81.06% |
| 2014-12-31 | ₹0.90 B | 59.68% |
| 2013-12-31 | ₹0.56 B | 268.45% |
| 2012-12-31 | ₹0.15 B | -71.19% |
| 2011-12-31 | ₹0.53 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Alkermes ALKS | ₹49.42 B | 889.31% | 🇮🇪 Ireland |
 Alnylam Pharmaceuticals
ALNY | ₹355.12 B | 7,008.33% | 🇺🇸 USA |
 Amarin Corporation
AMRN | ₹15.76 B | 215.65% | 🇮🇪 Ireland |